MDS Inc.
Toronto symbol MDS, operates in three medical-related fields: contract drug research, analytical devices and medical isotopes for cancer treatments.
MDS INC. $7.43 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 121.1 million; Market cap: $899.8 million; Price-to-sales ratio: 0.5; SI Rating: Average) lost $233 million or $1.91 a share in the fiscal year ended October 31, 2008 (all amounts except share price and market cap in U.S. dollars). The loss was mainly due to writedowns, including a …read more »
INDIGO BOOKS & MUSIC INC. $14 (Toronto symbol IDG; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 24.7 million; Market cap: $345.8 million; SI Rating: Extra risk) earned $3.2 million in its second fiscal quarter ended September 27, 2008, down 4.5% from $3.3 million a year earlier. Earnings per share were unchanged at $0.13. Sales fell 1.9%, to $205.3 million from …read more »
MDS INC. $20 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 122.4 million; Market cap: $2.4 billion; SI Rating: Average) operates in three medical-related fields: contract drug research (roughly 45% of revenue), analytical devices (35%) and medical isotopes for cancer treatments (20%).
The stock fell to $16 in February 2008 after the nuclear reactor that supplies the bulk of …read more »
MDS INC. $19 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 122.5 million; Market cap: $2.3 billion; SI Rating: Average) is now 16.8% owned by activist investor ValueAct Capital Management LLC. That’s up from 6.6% in May, 2007. ValueAct will likely spur MDS to move more aggressively with its current restructuring plan.
Meanwhile, MDS has agreed to sell two …read more »
MDS INC. $22 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 122.5 million; Market cap: $2.7 billion; SI Rating: Average) has completed reviews of about 85% of the tests performed at its Montreal drug-testing lab, as requested by the U.S. Food and Drug Administration. European regulators may also ask for more data, but the FDA audits should satisfy …read more »
MDS INC. $22 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 122.5 million; Market cap: $2.7 billion; SI Rating: Average) operates in three medical -related fields: contract drug research, analytical devices and medical isotopes.
The company now spends about 2% of its revenue on research, down from 3% a few years ago. That’s because it sold the research-intensive parts …read more »
MDS INC. $22 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 121.9 million; Market cap: $2.7 billion; SI Rating: Average) has repurchased 15.8% of its outstanding common shares at $21.90 each under a Dutch Auction. The buyback cost MDS $499.3 million. To put that in context, the company lost $0.02 U.S. a share (total $2.0 million U.S.) from …read more »
CANADIAN PACIFIC RAILWAY LTD. $64 (Toronto symbol CP) expects earnings in 2007 will rise 10% to $4.40 a share. Improving efficiencies should offset slowing coal volumes. Growing demand for other resources like potash should increase 2007 revenue by 5%. Best Buy.
ALCAN INC. $57 (Toronto symbol AL) plans to build a new aluminum smelter in South Africa, and has arranged a …read more »
MDS INC. $19 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; SI Rating: Average) is still having problems with its drug-testing lab in Montreal, which is currently under review by the U.S. Food and Drug Administration.
The company estimates that this review cut its earnings by $10 million in its third fiscal quarter ended July 31, 2006. MDS earned $0.15 a …read more »
MDS INC. $21 (Toronto symbol MDS; SI Rating: Above average) soared for us since we first recommended it at $3.75 a share (adjusted for splits) in April 1995. But it has struggled in the past few years, as costly investments in emerging fields like protein research failed to live up to expectations.
It also had to write off its equity investments …read more »
